Why the study?
Does age influence the haemodynamic, renal, and cGMP responses to a bolus dose of atrial natriuretic factor in healthy volunteers?
Does age influence the haemodynamic, renal, and cGMP responses to a bolus dose of atrial natriuretic factor in healthy volunteers?
Sensitivity to atrial natriuretic factor increases with age, resulting in greater haemodynamic and renal responses, which underscores the necessity of using age-matched controls in clinical studies of ANF.
Answers are grounded in this paper and cite their sources.
Supports age-matched controls in ANF studies; leaves open clinical relevance for elderly patients.
We assessed the haemodynamic and renal effects as well as the effects on plasma cGMP levels of a small i.v. dose (33 micrograms) of human atrial natriuretic factor (99-126; hANF) in two age groups of healthy volunteers. Binding properties of platelet ANF receptors were also measured. The elderly (four males, eight females, mean age 52.3 years) showed increased haemodynamic (decrease in blood pressure) and renal responses (diuresis, natriuresis, calciuresis) as well as greater increases in plasma cGMP levels and urinary cGMP excretion than the young subjects (four males, 12 females, mean age 26 years). Binding capacities and affinities of platelet ANF receptors were identical in both groups. These data indicate that the sensitivity to ANF increases with age and that this increased sensitivity is reflected in the reactivity of plasma cGMP levels but not in the properties of platelet ANF receptors. The data may be important for the therapeutic use of ANF, for the understanding of the physiological regulation of ANF action and may underline the necessity of using age-matched control subjects for clinical studies on the possible therapeutic effectiveness of ANF.
No takes yet. Share an insight, caveat, or question.
Heim et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: